Most patients with bowel cancer not advised to exercise despite its health benefits
the ONA take:
Many patients with bowel cancer say they were not advised to exercise regularly after diagnosis. Exercise can help ease fatigue, depression, and anxiety; is linked to better survival and better quality of life for patients; and reduces the risk of recurrence.
However, a Cancer Research UK study has shown that many patients are not advised to be more active.
The researchers asked more than 15,000 patients with bowel cancer about their current level of exercise and whether they were advised to be more active.
Only 31% said they were advised to exercise at any point during their treatment, 69% said they were not advised at all.
Current NHS guidelines recommend that healthy people get at least 2.5 hours of moderate physical activity per week.
Although no guidelines specific to patients with bowel cancer are in place, the researchers recommend that patients discuss exercise with their doctor and get advice on what is safe for them and suits their lifestyle and ability.
Many patients with bowel cancer say they were not advised to exercise regularly after diagnosis.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|